| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| tilskud bestående af gamma-linolensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Gamolenic acid adverse reaction |
Causative agent |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Allergy to gamolenic acid (finding) |
Causative agent |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Gamolenic acid overdose |
Causative agent |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Accidental gamolenic acid overdose |
Causative agent |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Intentional gamolenic acid overdose |
Causative agent |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| overdosis af gamolensyre, uvist med hvilken hensigt |
Causative agent |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Gamolenic acid 80 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Gamolensyre 80 mg pædiatrisk kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Gamolensyre 20 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| Natlysolie 20 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
|
| alphatocopherol + gamolensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing gamolenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Allergy to gamolenic acid (finding) |
Causative agent |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolenic acid 80 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolenic acid 80 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolenic acid 80 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing gamolenic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolenic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing only gamolenic acid and vitamin E (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing only gamolenic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamma-linolenic acid intake (observable entity) |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
2 |
| Product containing alpha-tocopherol and gamolenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Alpha-tocopherol and gamolenic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolenic acid 120 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamolenic acid 120 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
| Gamma-linolenic acid intake (observable entity) |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Gamolenic acid (substance) |
Inferred relationship |
Some |
2 |
| Gamma-linolenic acid requirement |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
2 |
| Gamma-linolenic acid intake (observable entity) |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Gamolenic acid (substance) |
Inferred relationship |
Some |
1 |
FHIR